About private equity
How private equity invests in privately-owned businesses, supports jobs and creates prosperity.
Section Highlights
DPA Microphones
Amplifying one of Europe’s most innovative audio-visual businesses
02 Jul 2019
Euromed
Nurturing a Spanish leader in herbal extracts
02 Jul 2019
Grapeshot
Transforming a UK tech start-up into a global online marketing tool
04 Apr 2019About us
We represent Europe’s private equity, venture capital and infrastructure industry.
Section Highlights
Industry standards
Invest Europe is the guardian of the industry’s professional standards.
Section Highlights
Policy
Working with policymakers to develop legislation that helps drive growth and prosperity.
Section Highlights
Research
The authoritative data source on European private equity activity.
Section Highlights
Events & training
A comprehensive suite of conferences, networking events and training courses.
Section Highlights
News & opinion
Up-to-the-minute policy and industry news, insights and opinions.
Section Highlights
Members
Login to access your exclusive member-only content and account information.
Login
Not a member? Join us
- Operate to the highest level of professional standards
- Access authoritative industry research and data
- Navigate the complex EU regulatory environment
- Network and engage with industry leaders
Riverside invested in Euromed, a producer of standardised herbal extracts and natural active substances for the pharmaceutical, nutraceutical, food and cosmetic industries, in 2015. Euromed processes more than 5,000 tons of raw materials every year to produce high-quality extracts to meet the needs of more than 300 customers in 35 countries worldwide.
During Riverside’s three-year hold, Euromed’s sales grew at a CAGR in excess of 16% and earnings doubled. Euromed also acquired ProbelteBio as an add-on, enhancing production capacity by approximately 30% and providing complementary products to the portfolio. The add-on brought the necessary production capacity to sustain growth for the future. Riverside sold the business to trade buyer Dermapharm in 2018, realising a strong return for investors.
Javier Roig
CEO
Euromed
increase in production capacity
CAGR in sales
What did the business need?
- Investment for new product launches
- International expansion
- Increased production capacity
- Enhancing sales of value-added products
How did private equity backing create lasting value?
- Added new processes and best practices – especially relating to R&D and new product development
- Increased the R&D team and built a new R&D centre
- Enhanced management, adding a new CFO, COO, Scientific Marketing Officer
- Enhanced the international sales team
- Completed the add-on acquisition of ProbelteBio
What outcomes did private equity investment achieve?
- Increased sales by more than 16% CAGR and doubled EBITDA in three years
- Developed an innovation culture at the company
- Enhanced the dietary supplements and functional food extracts business line
- Improved working capital management